ArticleBMC cancer2023

ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma.

Shuochen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.